Autori: Artosi F., Lanna C., Gaeta Shumak R., Borselli C., Costanza G., Rivieccio A., Orsini D., Lambiase S., Diluvio L., Bianchi L., Campione E.
Tildrakizumab as a potential option for early psoriatic arthritis in patients with metabolic comorbidities and psoriasis: a case series. Dermatology Practical & Conceptual, 2025. DOI: 10.5826/dpc.1504a5570